Diseases, Conditions, Syndromes

Researchers develop a molecule that blocks SARS-CoV-2 infection

A research team at Aarhus University has developed a new molecule that attaches to the surface of SARS-CoV-2 virus particles. This attachment prevents the virus from entering human cells and spreading the infection.

Diseases, Conditions, Syndromes

Mechanism underlying the emergence of virus variants unravelled

An international consortium, led by Delft University of Technology and the University of North Carolina, has for the first time succeeded in probing the molecular origins of recombination in RNA viruses. Hiccups during the ...

Diseases, Conditions, Syndromes

Monitoring SARS-CoV-2 using wastewater-based epidemiology

Alternative viral detection methods have been critical in the fight against COVID-19, helping to reduce the burden on our healthcare system. In a new study published in Applied and Environmental Microbiology, University of ...

Diseases, Conditions, Syndromes

What you need to know about the Delta variant

For more than 40 years, UCI infectious disease researcher Michael Buchmeier has studied coronaviruses, and he's one of the leading experts on SARS-CoV-2, the version of the virus causing the COVID-19 pandemic. As a more lethal ...

Diseases, Conditions, Syndromes

The enzyme that allows coronavirus to resist antiviral medications

The coronavirus that causes COVID-19 has demonstrated a stubborn ability to resist most nucleoside antiviral treatments, but a new study led by an Iowa State University scientist could help to overcome the virus's defenses.

page 7 from 30